Literature DB >> 7740809

Nonsurgical treatment of hepatocellular carcinoma in cirrhotic patients.

M Ohto1, M Yoshikawa, H Saisho, M Ebara, N Sugiura.   

Abstract

Modern imaging modalities have allowed us to make reliable diagnosis of hepatocellular carcinoma (HCC). Most of HCCs are associated with liver cirrhosis in varying stages of severity and often accompanied by new occurrences of HCC after treatment. Now, newly developed nonsurgical therapeutic modalities are used extensively and achieve good results in terms of anti-tumor effects as well as post-treatment survival.

Entities:  

Mesh：

Year:  1995        PMID： 7740809     DOI： 10.1007/BF00316978

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


  5 in total

1.  Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil.

Authors:  H Kasugai; J Kojima; M Tatsuta; S Okuda; Y Sasaki; S Imaoka; M Fujita; S Ishiguro
Journal:  Gastroenterology       Date:  1989-10       Impact factor: 22.682

2.  Percutaneous transaxillary catheter insertion for hepatic artery infusion chemotherapy.

Authors:  M Yoshikawa; M Ebara; T Nakano; A Minoyama; N Sugiura; M Ohto
Journal:  AJR Am J Roentgenol       Date:  1992-04       Impact factor: 3.959

3.  Hepatic artery embolization in 120 patients with unresectable hepatoma.

Authors:  R Yamada; M Sato; M Kawabata; H Nakatsuka; K Nakamura; S Takashima
Journal:  Radiology       Date:  1983-08       Impact factor: 11.105

4.  [A combination treatment of transcatheter arterial embolization (TAE) and irradiation for hepatocellular carcinoma (HCC)--evaluation for therapeutic efficacy in comparison with TAE or irradiation alone].

Authors:  M Yoshikawa; M Ebara; M Ohto; T Miyoshi
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1990-02

5.  Transcatheter embolization of hepatocellular carcinoma: assessment of efficacy in cases of resection following embolization.

Authors:  H Nakamura; T Tanaka; S Hori; H Yoshioka; C Kuroda; J Okamura; M Sakurai
Journal:  Radiology       Date:  1983-05       Impact factor: 11.105
  5 in total
  10 in total

1.  Effect of preoperative portal vein embolization on major hepatectomy for advanced-stage hepatocellular carcinomas in injured livers: a preliminary report.

Authors:  H Wakabayashi; S Okada; T Maeba; H Maeta
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

Review 2.  New progress of non-surgical treatments for hepatocellular carcinoma.

Authors:  Ji-Wen Cheng; Yi Lv
Journal:  Med Oncol       Date:  2013-01-06       Impact factor: 3.064

3.  Is transarterial chemoembolization beneficial for patients with diffuse infiltrative hepatocellular carcinoma?

Authors:  Tsung-Hsing Hung; Chen-Chi Tsai; Chung-Chi Lin; Hsing-Feng Lee; Chi-Jen Chu; Han-Chieh Lin
Journal:  Hepatol Int       Date:  2012-07-27       Impact factor: 6.047

4.  Helical tomotherapy for single and multiple liver tumours.

Authors:  Tsair-Fwu Lee; Pei-Ju Chao; Fu-Min Fang; Te-Jen Su; Stephen W Leung; Hsuan-Chih Hsu
Journal:  Radiat Oncol       Date:  2010-06-24       Impact factor: 3.481

5.  Comparison of coplanar and noncoplanar intensity-modulated radiation therapy and helical tomotherapy for hepatocellular carcinoma.

Authors:  Chen-Hsi Hsieh; Chia-Yuan Liu; Pei-Wei Shueng; Ngot-Swan Chong; Chih-Jen Chen; Ming-Jen Chen; Ching-Chung Lin; Tsang-En Wang; Shee-Chan Lin; Hung-Chi Tai; Hui-Ju Tien; Kuo-Hsin Chen; Li-Ying Wang; Yen-Ping Hsieh; David Y C Huang; Yu-Jen Chen
Journal:  Radiat Oncol       Date:  2010-05-23       Impact factor: 3.481

6.  Hepatitis C virus infection is a risk factor for tumor recurrence after resection of small hepatocellular carcinomas.

Authors:  Teh-Ia Huo; Jaw-Ching Wu; Cheng-Yuan Hsia; Gar-Yang Chau; Wing-Yiu Lui; Yi-Hsiang Huang; Pui-Ching Lee; Full-Young Chang; Shou-Dong Lee
Journal:  World J Surg       Date:  2004-08-03       Impact factor: 3.352

7.  Radiotherapy for 65 patients with advanced unresectable hepatocellular carcinoma.

Authors:  Yeon Seok Seo; Jin Nam Kim; Bora Keum; Sanghoon Park; Yong Dae Kwon; Yong Sik Kim; Yoon Tae Jeen; Hoon Jai Chun; Chul Yong Kim; Chang Duck Kim; Ho Sang Ryu; Soon Ho Um
Journal:  World J Gastroenterol       Date:  2008-04-21       Impact factor: 5.742

8.  Deterioration of hepatic functional reserve in patients with hepatocellular carcinoma after resection: incidence, risk factors, and association with intrahepatic tumor recurrence.

Authors:  Teh-Ia Huo; Wing-Yu Lui; Jaw-Ching Wu; Yi-Hsiang Huang; Kuang-Liang King; Che-Chuan Loong; Pui-Ching Lee; Full-Young Chang; Shou-Dong Lee
Journal:  World J Surg       Date:  2004-02-17       Impact factor: 3.352

9.  Volumetric intensity-modulated Arc (RapidArc) therapy for primary hepatocellular carcinoma: comparison with intensity-modulated radiotherapy and 3-D conformal radiotherapy.

Authors:  Yu-Cheng Kuo; Ying-Ming Chiu; Wen-Pin Shih; Hsiao-Wei Yu; Chia-Wen Chen; Pei-Fong Wong; Wei-Chan Lin; Jeng-Jong Hwang
Journal:  Radiat Oncol       Date:  2011-06-21       Impact factor: 3.481

10.  Ambovex(®) as a novel immunological modulator drug for the treatment of hepatocellular carcinoma (HCC) in the liver: a Phase II clinical trial.

Authors:  Hosny Salama; Hassan Ahmad; Ismail Elchagea; Abdel Rahman Zekri; Eman Medhat; Abeer Bahnassy; Michael Lange; Mohammed Rabbat; Andrew N de la Torre; Pravin Punamiya
Journal:  J Hepatocell Carcinoma       Date:  2015-06-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.